Victory Capital Management
NTRP

Victory Capital Management’s Neurotrope, Inc. Common NTRP Stock Holding History

Victory Capital Management’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,950
Closed -$4K – 3652
2020
Q1 		$4K Buy
+5,950
New +$6.49K ﹤0.01% 3594
2019
Q4 		– Sell
-2,024
Closed -$2K – 3627
2019
Q3 		$2K Buy
+2,024
New +$9.28K ﹤0.01% 3672

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFAS
Acorn Financial Advisory Services Reston, Virginia $753M AUM 36.94% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTP
Platform Technology Partners New York $519M AUM 20% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Victory Capital Management's NTRP Position: Q2 2020 in Review

Victory Capital Management sold out of Neurotrope, Inc. Common (NTRP) in Q2 2020, closing a stake of 5,950 shares — an estimated $4K sold.

Victory Capital Management first reported a position in NTRP in Q3 2019 and held it in 2 quarters. The position peaked at $4K in Q1 2020. 31 funds tracked by Wall St. Rank hold NTRP as of Q2 2020.

  • Victory Capital Management reported no remaining Neurotrope, Inc. Common position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 5,950 Neurotrope, Inc. Common shares in Q2 2020, an estimated $4K.
  • Victory Capital Management first reported a position in Neurotrope, Inc. Common in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Neurotrope, Inc. Common position peaked at $4K in Q1 2020.
  • 31 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.